1/21
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
tumor suppressor gene inactivation
retinoblastoma
oncogene activation by chromosomal translocation
chronic myeloid leukemia
oncogene amplification in breast cancer
HER2/NEU
most common cause of heredity colorectal cancer
lynch syndrome
somatic colon cancer mutation (associated with MSI and CpG island)
*methylated MLH1 promoter mutation
BRAF and CRC
another common cause of hereditary colorectal cancer
FAP
- Autosomal recessive inheritance
*milder FAP
- 2 common mutations (Y179C and G382D)
MUTYH associated polyposis (MAP)
causes of hereditary breast cancer
BRAC1, BRACA2, TP53, PTEN
increases risk for breast and ovarian cancer in BRAC1 or 2 genes
hereditary breast and ovarian cancer syndrome (HBOC)
breast (male and female)
ovarian
*possibly prostate
BRCA 1 associated cancers
breast (male and female)
ovarian
*maybe pancreatic, melanoma, laryngeal
BRCA 2 associated cancers
aggressive type of breast cancer correlated inc risk with mutations in BRCA 1 and 2
triple negative breast cancer
homozygous for mutations in BRCA2
Fanconi anemia
Partner and localizer of BRCA2, risk for breast cancer and pancreatic cancer higher
homozygous mutations: Fanconi Anemia
PALB2
PTEN gene
*inc risks for breast, thyroid, endometrical, renal, colon
cowden syndrome
TP 53 gene mutation
li-fraumeni syndrome
CDKN2A and CDK 4
familial melanoma
gain of function mutation in RET protooncogene
multiple endocrine neoplasia
IRF6 mutation
autosomal dominant
van der woude syndrome
CT disorder
autosomal dominant
mutation in COL2A1
stickler syndrome
congenital heart disease with CP
22q11.2
clinical features: some paralysis of lower extremities, difficulty control bowel and bladder hydrocephalus, normal intellect in 70%
spina bifida